Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Participants With Spinal Muscular Atrophy

ClinicalTrials.gov ID: NCT05337553

Public ClinicalTrials.gov record NCT05337553. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 10:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Ambulatory and Non-Ambulatory Participants With Spinal Muscular Atrophy With Open-Label Extension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial will study the efficacy and safety of taldefgrobep alfa as an adjunctive therapy for participants who are already taking a stable dose of nusinersen and/or risdiplam and/or have a history of onasemnogene abeparvovec, compared to placebo.

Study identification

NCT ID
NCT05337553
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Biohaven Pharmaceuticals, Inc.
Industry
Enrollment
269 participants

Conditions and interventions

Eligibility (public fields only)

Age range
4 Years to 21 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 6, 2022 (Actual)
Primary completion
Sep 25, 2024 (Actual)
Completion
Dec 2027 (Estimated)
Last update posted
Jun 1, 2026

2022 – 2027

United States locations

U.S. sites
30
U.S. states
21
U.S. cities
30
Facility City State ZIP Site status
Phoenix Children's Phoenix Arizona 85016 —
UCSD & Rady Children's La Jolla California 92037 —
Children's Hospital of Los Angeles Los Angeles California 90027 —
UCSF Benioff Children's Hospital, Medical Center San Francisco California 94158 —
Children's Hospital Colorado Aurora Colorado 80045 —
UF Health, Shands Hospital Gainesville Florida 32610 —
Rare Disease Research Atlanta Georgia 30329 —
Northwestern University - Feinberg School of Medicine - Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
Indiana University -Riley Research Indianapolis Indiana 46202 —
University of Iowa Iowa City Iowa 52242 —
University of Kansas Medical Center Fairway Kansas 66205 —
Boston Children's Hospital - Harvard Boston Massachusetts 02115 —
BSHS Office of Research Grand Rapids Michigan 49503 —
Washington University in St. Louis St Louis Missouri 63110 —
Columbia University Medical Center New York New York 10032 —
Stony Brook University Hospital Stony Brook New York 11794 —
Duke University Medicine Durham North Carolina 27705 —
Cincinnati Children's Hospital Medical Center Cincinnati Ohio 45229 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Penn State College of Medicine Hershey Pennsylvania 17033 —
CHOP Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 —
UPMC Children's Hospital of Pittsburgh Pittsburgh Pennsylvania 15224 —
Vanderbilt University Medical Center Nashville Tennessee 37232 —
UT Pediatric Neurosciences/Dell Children's Medical Center Austin Texas 78723 —
Neurology Rare Disease Center Denton Texas 75208 —
Cook Children's Hospital Fort Worth Texas 76104 —
University of Virginia Children's Hospital Charlottesville Virginia 22903 —
Children's Hospital of The King's Daughters Norfolk Virginia 23507 —
MultiCare Institute of Research and Innovation Tacoma Washington 98405 —
Medical College of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05337553, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05337553 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →